QQQ   360.11 (+0.59%)
AAPL   172.00 (+0.77%)
MSFT   317.56 (+1.25%)
META   305.65 (+0.56%)
GOOGL   132.05 (-0.20%)
AMZN   127.72 (+1.38%)
TSLA   252.16 (+2.35%)
NVDA   437.38 (+1.51%)
NIO   9.06 (+1.68%)
BABA   87.00 (+1.71%)
AMD   103.83 (+1.04%)
T   15.00 (-0.07%)
F   12.60 (+0.32%)
MU   68.02 (+4.33%)
CGC   0.81 (-0.42%)
GE   110.74 (-1.42%)
DIS   80.84 (+0.89%)
AMC   8.00 (+2.70%)
PFE   32.85 (+2.37%)
PYPL   58.69 (+0.88%)
NFLX   377.45 (+0.29%)
QQQ   360.11 (+0.59%)
AAPL   172.00 (+0.77%)
MSFT   317.56 (+1.25%)
META   305.65 (+0.56%)
GOOGL   132.05 (-0.20%)
AMZN   127.72 (+1.38%)
TSLA   252.16 (+2.35%)
NVDA   437.38 (+1.51%)
NIO   9.06 (+1.68%)
BABA   87.00 (+1.71%)
AMD   103.83 (+1.04%)
T   15.00 (-0.07%)
F   12.60 (+0.32%)
MU   68.02 (+4.33%)
CGC   0.81 (-0.42%)
GE   110.74 (-1.42%)
DIS   80.84 (+0.89%)
AMC   8.00 (+2.70%)
PFE   32.85 (+2.37%)
PYPL   58.69 (+0.88%)
NFLX   377.45 (+0.29%)
QQQ   360.11 (+0.59%)
AAPL   172.00 (+0.77%)
MSFT   317.56 (+1.25%)
META   305.65 (+0.56%)
GOOGL   132.05 (-0.20%)
AMZN   127.72 (+1.38%)
TSLA   252.16 (+2.35%)
NVDA   437.38 (+1.51%)
NIO   9.06 (+1.68%)
BABA   87.00 (+1.71%)
AMD   103.83 (+1.04%)
T   15.00 (-0.07%)
F   12.60 (+0.32%)
MU   68.02 (+4.33%)
CGC   0.81 (-0.42%)
GE   110.74 (-1.42%)
DIS   80.84 (+0.89%)
AMC   8.00 (+2.70%)
PFE   32.85 (+2.37%)
PYPL   58.69 (+0.88%)
NFLX   377.45 (+0.29%)
QQQ   360.11 (+0.59%)
AAPL   172.00 (+0.77%)
MSFT   317.56 (+1.25%)
META   305.65 (+0.56%)
GOOGL   132.05 (-0.20%)
AMZN   127.72 (+1.38%)
TSLA   252.16 (+2.35%)
NVDA   437.38 (+1.51%)
NIO   9.06 (+1.68%)
BABA   87.00 (+1.71%)
AMD   103.83 (+1.04%)
T   15.00 (-0.07%)
F   12.60 (+0.32%)
MU   68.02 (+4.33%)
CGC   0.81 (-0.42%)
GE   110.74 (-1.42%)
DIS   80.84 (+0.89%)
AMC   8.00 (+2.70%)
PFE   32.85 (+2.37%)
PYPL   58.69 (+0.88%)
NFLX   377.45 (+0.29%)
LON:VRP

Verona Pharma plc (VRP.L) (VRP) Share Forecast, Price & News

GBX 55
+3.00 (+5.77%)
(As of 10/29/2020)
Today's Range
50
▼
56
50-Day Range
55
▼
55
52-Week Range
28.60
▼
115
Volume
70,791 shs
Average Volume
150,610 shs
Market Capitalization
£228.00 million
Assets Under Management
N/A
Dividend Yield
N/A
Net Expense Ratio
0.00%
ProfileChartHeadlinesOptions Chain
VRP stock logo

About Verona Pharma plc (VRP.L) (LON:VRP)

Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis. Verona Pharma plc was founded in 2005 and is headquartered in London, the United Kingdom.

VRP Price History

VRP ETF News Headlines

September 23, 2023 | americanbankingnews.com
Verona Pharma plc (VRP.L) (LON:VRP) Stock Passes Above 200-Day Moving Average of $55.00
September 5, 2023 | msn.com
Verona Pharma: De-Risked COPD Biotech Play, Approval Likely Coming Soon
September 29, 2023 | PressReach (Ad)
Uranium Prices Surge as Nuclear Energy Becomes Key
Renewed interest in uranium and rising prices have created a favorable environment for new projects.
September 2, 2023 | msn.com
Canaccord Genuity Reiterates Verona Pharma Plc - ADR (VRNA) Buy Recommendation
September 1, 2023 | benzinga.com
Expert Ratings for Verona Pharma
August 31, 2023 | benzinga.com
Christina Ackermann Joins Verona Pharma as Non-Executive Director
August 4, 2023 | markets.businessinsider.com
H.C. Wainwright Keeps Their Buy Rating on Verona Pharma (VRNA)
July 26, 2023 | benzinga.com
Verona Pharma to Present at 43rd Annual Canaccord Growth Conference
September 29, 2023 | PressReach (Ad)
Uranium Prices Surge as Nuclear Energy Becomes Key
Renewed interest in uranium and rising prices have created a favorable environment for new projects.
July 20, 2023 | benzinga.com
Verona Pharma to Report Second Quarter 2023 Financial Results and Provide Corporate Update
See More Headlines
Receive VRP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Verona Pharma plc (VRP.L) and its competitors with MarketBeat's FREE daily newsletter.

20 Stocks to Sell Now Cover
20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Verona Pharma plc (VRP.L) (VRP)

Full Holdings Details

Key Executives

  • Dr. Jan-Anders Karlsson (Age 64)
    CEO & Exec. Director
  • Mr. Piers John Morgan (Age 53)
    Chief Financial Officer
  • Ms. Claire Louise Poll L.C.S.W. (Age 52)
    B.A., B Juris, LLB, ASIA, Gen. Counsel
  • Ms. Victoria Stewart
    Director of Communications
  • Dr. Peter Spargo (Age 57)
    Sr. VP of Chemistry Manufacturing & Controls













VRP ETF - Frequently Asked Questions

How have VRP shares performed in 2023?

Verona Pharma plc (VRP.L)'s stock was trading at GBX 55 at the start of the year. Since then, VRP shares have increased by 0.0% and is now trading at GBX 55.
View the best growth stocks for 2023 here.

How were Verona Pharma plc (VRP.L)'s earnings last quarter?

Verona Pharma plc (VRP.L) (LON:VRP) issued its earnings results on Thursday, February, 27th. The company reported ($30.30) EPS for the quarter, beating the consensus estimate of ($30.80) by $0.50.

What other stocks do shareholders of Verona Pharma plc (VRP.L) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Verona Pharma plc (VRP.L) investors own include Verona Pharma (VRNA), Fate Therapeutics (FATE), Pluristem Therapeutics (PSTI), AbbVie (ABBV), BioMarin Pharmaceutical (BMRN), Exelixis (EXEL), Amicus Therapeutics (FOLD), Global Blood Therapeutics (GBT), Grifols (GRFS) and Innoviva (INVA).

What is Verona Pharma plc (VRP.L)'s stock symbol?

Verona Pharma plc (VRP.L) trades on the London Stock Exchange (LON) under the ticker symbol "VRP."

How do I buy shares of Verona Pharma plc (VRP.L)?

Shares of VRP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Verona Pharma plc (VRP.L)'s stock price today?

One share of VRP stock can currently be purchased for approximately GBX 55.

How much money does Verona Pharma plc (VRP.L) make?

Verona Pharma plc (VRP.L) (LON:VRP) has a market capitalization of £228.00 million.

How can I contact Verona Pharma plc (VRP.L)?

Verona Pharma plc (VRP.L)'s mailing address is 3 More London Riverside, LONDON, SE1 2RE, United Kingdom. The official website for the company is www.veronapharma.com. The company can be reached via phone at +44-20-32834200.

This page (LON:VRP) was last updated on 9/29/2023 by MarketBeat.com Staff

My Account -